UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Potential Roles of Redox Dysregulation in the Development of Schizophrenia

Biological psychiatry (1969), 2020-08, Vol.88 (4), p.326-336

2020

Volltextzugriff (PDF)

Towards a psychosis risk blood diagnostic for persons experiencing high-risk symptoms: preliminary results from the NAPLS project

Schizophrenia bulletin, 2015-03, Vol.41 (2), p.419-428

2015

Volltextzugriff (PDF)

Relationship Between Duration of Untreated Psychosis and Outcome in First-Episode Schizophrenia: A Critical Review and Meta-Analysis

The American journal of psychiatry, 2005-10, Vol.162 (10), p.1785-1804

2005

Volltextzugriff (PDF)

The Dark Side of the Moon: Meta-analytical Impact of Recruitment Strategies on Risk Enrichment in the Clinical High Risk State for Psychosis

Schizophrenia bulletin, 2016-05, Vol.42 (3), p.732-743

2016

Volltextzugriff (PDF)

Polygenic Risk Score Contribution to Psychosis Prediction in a Target Population of Persons at Clinical High Risk

The American journal of psychiatry, 2020-02, Vol.177 (2), p.155-163

2020

Volltextzugriff (PDF)

At Clinical High Risk for Psychosis: Outcome for Nonconverters

The American journal of psychiatry, 2011-08, Vol.168 (8), p.800-805

2011

Volltextzugriff (PDF)

North American Prodrome Longitudinal Study (NAPLS 2): Overview and recruitment

Schizophrenia research, 2012-12, Vol.142 (1), p.77-82

2012

Volltextzugriff (PDF)

Nuclear and cytoplasmic localization of neural stem cell microRNAs

RNA (Cambridge), 2011-04, Vol.17 (4), p.675-686

2011

Volltextzugriff (PDF)

Cortisol Levels and Risk for Psychosis: Initial Findings from the North American Prodrome Longitudinal Study

Biological psychiatry (1969), 2013-09, Vol.74 (6), p.410-417

2013

Volltextzugriff (PDF)

Negative symptoms in individuals at clinical high risk of psychosis

Psychiatry research, 2012-04, Vol.196 (2), p.220-224

2012

Volltextzugriff (PDF)

Validity of the Prodromal Risk Syndrome for First Psychosis: Findings From the North American Prodrome Longitudinal Study

Schizophrenia bulletin, 2009-09, Vol.35 (5), p.894-908

2009

Volltextzugriff (PDF)

Social functioning in individuals at clinical high risk for psychosis

Schizophrenia research, 2008-02, Vol.99 (1), p.119-124

2008

Volltextzugriff (PDF)

A Randomized Trial Examining the Effectiveness of Switching From Olanzapine, Quetiapine, or Risperidone to Aripiprazole to Reduce Metabolic Risk: Comparison of Antipsychotics for Metabolic Problems (CAMP)

The American journal of psychiatry, 2011-09, Vol.168 (9), p.947-956

2011

Volltextzugriff (PDF)

Efficacy and Tolerability of Olanzapine, Quetiapine, and Risperidone in the Treatment of Early Psychosis: A Randomized, Double-Blind 52-Week Comparison

The American journal of psychiatry, 2007-07, Vol.164 (7), p.1050-1060

2007

Volltextzugriff (PDF)

Social decline in the psychosis prodrome: Predictor potential and heterogeneity of outcome

Schizophrenia research, 2021-01, Vol.227, p.44-51

2021

Volltextzugriff (PDF)

Premorbid functional development and conversion to psychosis in clinical high-risk youths

Development and psychopathology, 2013-11, Vol.25 (4pt1), p.1171-1186

2013

Volltextzugriff (PDF)

A greedy regression algorithm with coarse weights offers novel advantages

Scientific reports, 2022-03, Vol.12 (1), p.5440-14, Article 5440

2022

Volltextzugriff (PDF)

Effects of Olanzapine, Quetiapine, and Risperidone on Neurocognitive Function in Early Psychosis: A Randomized, Double-Blind 52-Week Comparison

The American journal of psychiatry, 2007-07, Vol.164 (7), p.1061-1071

2007

Volltextzugriff (PDF)

A longitudinal study of neurocognitive function in individuals at-risk for psychosis

Schizophrenia research, 2006-12, Vol.88 (1), p.26-35

2006

Volltextzugriff (PDF)

Implications for the Neural Basis of Social Cognition for the Study of Schizophrenia

The American journal of psychiatry, 2003-05, Vol.160 (5), p.815-824

2003

Volltextzugriff (PDF)

The impact of early factors on persistent negative symptoms in youth at clinical high risk for psychosis

Frontiers in psychiatry, 2023-05, Vol.14, p.1125168-1125168

2023

Volltextzugriff (PDF)

Genome-Wide Pharmacogenomic Study of Neurocognition As an Indicator of Antipsychotic Treatment Response in Schizophrenia

Neuropsychopharmacology (New York, N.Y.), 2011-02, Vol.36 (3), p.616-626

2011

Volltextzugriff (PDF)

Current status specifiers for patients at clinical high risk for psychosis

Schizophrenia research, 2014-09, Vol.158 (1), p.69-75

2014

Volltextzugriff (PDF)

Hippocampal Connectivity With the Default Mode Network Is Linked to Hippocampal Volume in the Clinical High Risk for Psychosis Syndrome and Healthy Individuals

Clinical psychological science, 2023-09, Vol.11 (5), p.801-818

2023

Volltextzugriff (PDF)

Sexual dimorphisms and prediction of conversion in the NAPLS psychosis prodrome

Schizophrenia research, 2013-03, Vol.144 (1), p.43-50

2013

Volltextzugriff (PDF)

1 – 25 von 340

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(328)
Mit Volltextzugriff
(300)

Publikationsform

Sprache

Englisch
(340)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(238)
Life Sciences & Biomedicine
(234)
Humans
(225)
Psychiatry
(217)
Male
(156)
Female
(146)
Psychosis
(124)
Schizophrenia
(123)
Adult
(120)
Adolescent
(114)
Biological And Medical Sciences
(89)
Longitudinal Studies
(88)
Medical Sciences
(83)
Young Adult
(81)
Psychology. Psychoanalysis. Psychiatry
(79)
Prodromal Symptoms
(73)
Psychopathology. Psychiatry
(65)
Clinical High Risk
(55)
Psychotic Disorders - Diagnosis
(52)
Psychotic Disorders - Psychology
(52)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

Potential Roles of Redox Dysregulation in the Development of Schizophrenia

Towards a psychosis risk blood diagnostic for persons experiencing high-risk symptoms: preliminary results from the NAPLS project

Relationship Between Duration of Untreated Psychosis and Outcome in First-Episode Schizophrenia: A Critical Review and Meta-Analysis

The Dark Side of the Moon: Meta-analytical Impact of Recruitment Strategies on Risk Enrichment in the Clinical High Risk State for Psychosis

Polygenic Risk Score Contribution to Psychosis Prediction in a Target Population of Persons at Clinical High Risk

At Clinical High Risk for Psychosis: Outcome for Nonconverters

North American Prodrome Longitudinal Study (NAPLS 2): Overview and recruitment

Nuclear and cytoplasmic localization of neural stem cell microRNAs

Cortisol Levels and Risk for Psychosis: Initial Findings from the North American Prodrome Longitudinal Study

Negative symptoms in individuals at clinical high risk of psychosis

Validity of the Prodromal Risk Syndrome for First Psychosis: Findings From the North American Prodrome Longitudinal Study

Social functioning in individuals at clinical high risk for psychosis

A Randomized Trial Examining the Effectiveness of Switching From Olanzapine, Quetiapine, or Risperidone to Aripiprazole to Reduce Metabolic Risk: Comparison of Antipsychotics for Metabolic Problems (CAMP)

Efficacy and Tolerability of Olanzapine, Quetiapine, and Risperidone in the Treatment of Early Psychosis: A Randomized, Double-Blind 52-Week Comparison

Social decline in the psychosis prodrome: Predictor potential and heterogeneity of outcome

Premorbid functional development and conversion to psychosis in clinical high-risk youths

A greedy regression algorithm with coarse weights offers novel advantages

Effects of Olanzapine, Quetiapine, and Risperidone on Neurocognitive Function in Early Psychosis: A Randomized, Double-Blind 52-Week Comparison

A longitudinal study of neurocognitive function in individuals at-risk for psychosis

Implications for the Neural Basis of Social Cognition for the Study of Schizophrenia

The impact of early factors on persistent negative symptoms in youth at clinical high risk for psychosis

Genome-Wide Pharmacogenomic Study of Neurocognition As an Indicator of Antipsychotic Treatment Response in Schizophrenia

Current status specifiers for patients at clinical high risk for psychosis

Hippocampal Connectivity With the Default Mode Network Is Linked to Hippocampal Volume in the Clinical High Risk for Psychosis Syndrome and Healthy Individuals

Sexual dimorphisms and prediction of conversion in the NAPLS psychosis prodrome

Suchergebnisse filtern